Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Lam Research
LRCX
|
$792M |
| 2 |
Johnson & Johnson
JNJ
|
$659M |
| 3 |
Datadog
DDOG
|
$571M |
| 4 |
Amazon
AMZN
|
$474M |
| 5 |
Broadcom
AVGO
|
$458M |
Top Sells
| 1 |
Workday
WDAY
|
$1.23B |
| 2 |
AbbVie
ABBV
|
$1.03B |
| 3 |
Advanced Micro Devices
AMD
|
$686M |
| 4 |
Honeywell
HON
|
$673M |
| 5 |
Amgen
AMGN
|
$620M |
Sector Composition
| 1 | Technology | 34.72% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.22% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Travelers Companies
TRV
$62B
| $79.8M | 0.04% |
331,325
-8,576
| -3% | -$2.07M |
|
302
Liberty Media Series A
FWONA
$22.6B
| $79.7M | 0.04% |
948,907
+4,641
| +0.5% | +$390K |
|
303
CACI
CACI
$10.4B
| $79.3M | 0.04% |
196,384
+9,420
| +5% | +$3.81M |
|
304
Silgan Holdings
SLGN
$4.83B
| $78.9M | 0.04% |
1,515,582
+401,890
| +36% | +$20.9M |
|
|
VRNA
305
Verona Pharma
VRNA
$9.2B
| $77.5M | 0.04% |
1,667,165
+624,370
| +60% | +$29M |
|
306
Disc Medicine
IRON
$2.11B
| $77.2M | 0.04% |
1,217,815
+467,988
| +62% | +$29.7M |
|
307
Lattice Semiconductor
LSCC
$9.05B
| $76.8M | 0.04% |
1,357,119
+1,195,624
| +740% | +$67.7M |
|
308
AST SpaceMobile
ASTS
$11.4B
| $76.7M | 0.04% |
3,635,711
+6,626
| +0.2% | +$140K |
|
309
Exxon Mobil
XOM
$466B
| $76.4M | 0.04% |
709,539
+132,507
| +23% | +$14.3M |
|
310
Bank of America
BAC
$369B
| $75.8M | 0.04% |
1,723,030
+632,988
| +58% | +$27.8M |
|
311
Advanced Drainage Systems
WMS
$11.5B
| $74.4M | 0.04% |
644,056
+54,916
| +9% | +$6.35M |
|
312
American Homes 4 Rent
AMH
$12.9B
| $73.8M | 0.04% |
1,973,969
+38,962
| +2% | +$1.46M |
|
313
CGI
GIB
$21.6B
| $73.7M | 0.04% |
673,206
-14,341
| -2% | -$1.57M |
|
314
Churchill Downs
CHDN
$7.18B
| $72.9M | 0.04% |
545,912
+94,351
| +21% | +$12.6M |
|
315
Welltower
WELL
$112B
| $72.8M | 0.04% |
578,584
-534,528
| -48% | -$67.3M |
|
316
Bio-Techne
TECH
$8.46B
| $72.7M | 0.04% |
1,009,471
+12,305
| +1% | +$886K |
|
317
Entergy
ETR
$39.2B
| $72.6M | 0.04% |
957,111
-127,051
| -12% | -$9.63M |
|
318
Descartes Systems
DSGX
$9.26B
| $72.2M | 0.04% |
635,722
+3,554
| +0.6% | +$404K |
|
319
CBRE Group
CBRE
$48.9B
| $71.7M | 0.04% |
546,189
-107,089
| -16% | -$14.1M |
|
320
Praxis Precision Medicines
PRAX
$986M
| $71.6M | 0.04% |
929,523
+405,957
| +78% | +$31.3M |
|
321
Travere Therapeutics
TVTX
$1.93B
| $70.7M | 0.04% |
4,058,632
+4,026,819
| +12,658% | +$70.1M |
|
322
Fox Class B
FOX
$24.9B
| $70.3M | 0.04% |
1,536,614
-179,551
| -10% | -$8.21M |
|
323
Legend Biotech
LEGN
$6.66B
| $70.2M | 0.04% |
2,156,749
-28,885
| -1% | -$940K |
|
324
Lazard
LAZ
$5.32B
| $70.1M | 0.04% |
1,361,366
-150,683
| -10% | -$7.76M |
|
325
Ventas
VTR
$30.9B
| $68.7M | 0.03% |
1,166,840
+1,076,803
| +1,196% | +$63.4M |
|